| # | Drug | Count |
|---|---|---|
| 0 | SACUBITRIL AND VALSARTAN | 2511 |
| 1 | TRASTUZUMAB | 2057 |
| 2 | FUROSEMIDE | 1522 |
| 3 | ASPIRIN | 1175 |
| 4 | ASPIRIN 325 MG | 1143 |
| 5 | ASPIRIN 81 MG | 1143 |
| 6 | CYCLOPHOSPHAMIDE | 976 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 976 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 976 |
| 9 | CARVEDILOL | 959 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MAVACAMTEN | 224 | 0.0370 |
| 1 | TRASTUZUMAB | 2057 | 0.0296 |
| 2 | PERTUZUMAB | 722 | 0.0262 |
| 3 | ADO-TRASTUZUMAB EMTANSINE | 206 | 0.0244 |
| 4 | SACUBITRIL AND VALSARTAN | 2511 | 0.0216 |
| 5 | EPLERENONE | 241 | 0.0184 |
| 6 | LAPATINIB | 181 | 0.0117 |
| 7 | DABRAFENIB | 227 | 0.0107 |
| 8 | TRAMETINIB | 258 | 0.0106 |
| 9 | DOCETAXEL | 604 | 0.0089 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin 2 Receptor Blocker [EPC] | 2845 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 2148 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1747 |
| 3 | Loop Diuretic [EPC] | 1732 |
| 4 | Corticosteroid [EPC] | 1639 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 1188 |
| 6 | beta-Adrenergic Blocker [EPC] | 1160 |
| 7 | Alkylating Drug [EPC] | 1138 |
| 8 | Microtubule Inhibitor [EPC] | 1121 |
| 9 | Aldosterone Antagonist [EPC] | 1091 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific HER2-directed Antibody [EPC] | 4 | 0.0488 |
| 1 | Cardiac Myosin Inhibitor [EPC] | 224 | 0.0370 |
| 2 | Endoglycosidase [EPC] | 59 | 0.0318 |
| 3 | Vasoconstrictor [EPC] | 9 | 0.0300 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 2148 | 0.0287 |
| 5 | Lymphocyte Growth Factor [EPC] | 16 | 0.0127 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 71 | 0.0121 |
| 7 | Lead Chelator [EPC] | 1 | 0.0119 |
| 8 | Anthracycline Topoisomerase Inhibitor [EPC] | 25 | 0.0103 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 2845 | 0.0089 |